Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Pudil

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
Casopis Lekaru Ceskych|July 15, 2005
[Ischemia-modified albumin: new marker of myocardial ischemia?]J Dusek, M Tichý, J Stásek, et al.
Bone Marrow Transplantation|November 10, 2009
Glycogen phosphorylase BB could be a new biomarker for detection of cardiac toxicity during hematopoietic cell transplantation for hematological malignanciesJ M Horacek, L Jebavy, M Ulrychova, et al.
Experimental Oncology|November 16, 2007
Biochemical markers and assessment of cardiotoxicity during preparative regimen and hematopoietic cell transplantation in acute leukemiaJ M Horacek, R Pudil, M Tichy, et al.
Bratislavske Lekarske Listy|December 17, 2013
Glycogen phosphorylase BB as a potential marker of cardiac toxicity in patients treated with anthracyclines for acute leukemiaJ M Horacek, L Jebavy, M Vasatova, et al.
Acta Medica (Hradec Kralove)|February 12, 2002
The effect of trimetazidine on C-reactive protein, cytokines and adhesion molecules in the course of acute myocardial infarctionR Pudil, V Pidrman, J Krejsek, et al.
Casopis Lekaru Ceskych|December 13, 2005
[Acetylsalicylic acid (ASA) resistance in patients with ischemic heart disease (IHD) as bioindicator of the treatment strategy]J Malý, M Pecka, J Gregor, et al.
Annals of Clinical Biochemistry|November 25, 2010
High-sensitivity troponin T as a marker of myocardial injury after radiofrequency catheter ablationM Vasatova, R Pudil, M Tichy, et al.
Neoplasma|November 13, 2008
Multimarker approach to evaluation of cardiac toxicity during preparative regimen and hematopoietic cell transplantationJ M Horacek, M Tichy, R Pudil, et al.
Neoplasma|September 10, 2005
The use of biochemical markers in cardiotoxicity monitoring in patients treated for leukemiaJ M Horácek, R Pudil, M Tichý, et al.
Vnitrni Lekarstvi|January 15, 2005
[Syncope in ventricular tachycardia as a first clinical sign of patent ductus arteriosus in an adulthood]R Praus, P Parízek, P Cervinka, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Casopis Lekaru Ceskych|July 15, 2005
[Ischemia-modified albumin: new marker of myocardial ischemia?]J Dusek, M Tichý, J Stásek, et al.
Bone Marrow Transplantation|November 10, 2009
Glycogen phosphorylase BB could be a new biomarker for detection of cardiac toxicity during hematopoietic cell transplantation for hematological malignanciesJ M Horacek, L Jebavy, M Ulrychova, et al.
Experimental Oncology|November 16, 2007
Biochemical markers and assessment of cardiotoxicity during preparative regimen and hematopoietic cell transplantation in acute leukemiaJ M Horacek, R Pudil, M Tichy, et al.
Bratislavske Lekarske Listy|December 17, 2013
Glycogen phosphorylase BB as a potential marker of cardiac toxicity in patients treated with anthracyclines for acute leukemiaJ M Horacek, L Jebavy, M Vasatova, et al.
Acta Medica (Hradec Kralove)|February 12, 2002
The effect of trimetazidine on C-reactive protein, cytokines and adhesion molecules in the course of acute myocardial infarctionR Pudil, V Pidrman, J Krejsek, et al.
Casopis Lekaru Ceskych|December 13, 2005
[Acetylsalicylic acid (ASA) resistance in patients with ischemic heart disease (IHD) as bioindicator of the treatment strategy]J Malý, M Pecka, J Gregor, et al.
Annals of Clinical Biochemistry|November 25, 2010
High-sensitivity troponin T as a marker of myocardial injury after radiofrequency catheter ablationM Vasatova, R Pudil, M Tichy, et al.
Neoplasma|November 13, 2008
Multimarker approach to evaluation of cardiac toxicity during preparative regimen and hematopoietic cell transplantationJ M Horacek, M Tichy, R Pudil, et al.
Neoplasma|September 10, 2005
The use of biochemical markers in cardiotoxicity monitoring in patients treated for leukemiaJ M Horácek, R Pudil, M Tichý, et al.
Vnitrni Lekarstvi|January 15, 2005
[Syncope in ventricular tachycardia as a first clinical sign of patent ductus arteriosus in an adulthood]R Praus, P Parízek, P Cervinka, et al.
Pageof 5